To maximize protein coverage and the identification of proteins with biomarker utility, proteome profiles of representative breast cancer [MCF7/ER+ and SKBR3/HER2+] and non-tumorigenic (MCF10A) cell lines were generated for different stages of the cell cycle by nano-liquid chromatography (LC)-MS. This evidence concerns the gene ESR1 and breast carcinoma.